Roles of brain angiotensin II in cognitive function and dementia

International Journal of Hypertension

Volumn 2012, Issue , 2012, Pages

  Mogi, Masaki ^a   Iwanami, Jun ^a   Horiuchi, Masatsugu ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II;

BINDING AFFINITY; BINDING SITE; CHOLINERGIC SYSTEM; COGNITION; COGNITIVE DEFECT; DEMENTIA; DISEASE ASSOCIATION; DNA DAMAGE; HUMAN; MOLECULAR PATHOLOGY; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION;

EID: 84872150887     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.1155/2012/169649     Document Type: Review

References (67)

1. de Gasparo M., Catt K. J., Inagami T., Wright J. W., Unger T., International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacological Reviews 2000 52 3 415 472 2-s2.0-0033824138
2. Schmieder R. E., Hilgers K. F., Schlaich M. P., Schmidt B. M., Renin-angiotensin system and cardiovascular risk. The Lancet 2007 369 9568 1208 1219 2-s2.0-34047121150 10.1016/S0140-6736(07)60242-6 (Pubitemid 46527856)
3. Iwanami J., Mogi M., Iwai M., Horiuchi M., Inhibition of the renin-angiotensin system and target organ protection. Hypertension Research 2009 32 4 229 237 2-s2.0-68849130125 10.1038/hr.2009.5
4. Fogari R., Zoppi A., Effect of antihypertensive agents on quality of life in the elderly. Drugs and Aging 2004 21 6 377 393 2-s2.0-2342631217 10.2165/00002512-200421060-00003 (Pubitemid 38608506)
5. Fletcher A., Quality of life in the management of hypertension. Clinical and Experimental Hypertension 1999 21 5-6 961 972 2-s2.0-0032811390 (Pubitemid 29325493)
6. Wright J. W., Harding J. W., The brain RAS and Alzheimer's disease. Experimental Neurology 2010 223 2 326 333 2-s2.0-77952546615 10.1016/j.expneurol.2009.09.012
7. Mogi M., Horiuchi M., Effects of angiotensin II receptor blockers on dementia. Hypertension Research 2009 32 9 738 740 2-s2.0-70249088004 10.1038/hr.2009.110
8. Li N. C., Lee A., Whitmer R. A., Kivipelto M., Lawler E., Kazis L. E., Wolozin B., Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. British Medical Journal 2010 340 b5465 2-s2.0-74249110813 10.1136/bmj.b5465
9. Davies N. M., Kehoe P. G., Ben-Shlomo Y., Martin R. M., Associations of anti-hypertensive treatments with Alzheimer's disease, vascular dementia, and other dementias. Journal of Alzheimer's Disease 2011 26 4 699 708
10. Ohrui T., Matsui T., Yamaya M., Arai H., Ebihara S., Maruyama M., Sasaki H., Angiotensin-converting enzyme inhibitors and incidence of Alzheimer's disease in Japan [7]. Journal of the American Geriatrics Society 2004 52 4 649 650 2-s2.0-1842683231 10.1111/j.1532-5415.2004.52178-7.x (Pubitemid 38480653)
11. Saxby B. K., Harrington F., Wesnes K. A., McKeith I. G., Ford G. A., Candesartan and cognitive decline in older patients with hypertension: a substudy of the SCOPE trial. Neurology 2008 70 19 1858 1866 2-s2.0-43249112025 10.1212/01.wnl.0000311447.85948.78 (Pubitemid 351653953)
12. Anderson C., Teo K., Gao P., Arima H., Dans A., Unger T., Commerford P., Dyal L., Schumacher H., Pogue J., Paolasso E., Holwerda N., Chazova I., Binbrek A., Young J., Yusuf S., Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies. The Lancet Neurology 2011 10 1 43 53 2-s2.0-78650022206 10.1016/S1474-4422(10)70250-7
13. Kehoe P. G., Passmore P. A., The renin-angiotensin system and antihypertensive drugs in Alzheimer's disease: current standing of the angiotensin hypothesis? Journal of Alzheimer's Disease 2012 30 supplement 2 S251 S268
14. Wright J. W., Harding J. W., Brain renin-angiotensin-A new look at an old system. Progress in Neurobiology 2011 95 1 49 67 2-s2.0-79960675107 10.1016/j.pneurobio.2011.07.001
15. Gard P. R., The role of angiotensin II in cognition and behaviour. European Journal of Pharmacology 2002 438 1-2 1 14 2-s2.0-0036496910 10.1016/S0014-2999(02)01283-9 (Pubitemid 34242913)
16. Georgiev V., Yonkov D., Participation of angiotensin II in learning and memory. I. Interaction of angiotensin II with saralasin. Methods and Findings in Experimental and Clinical Pharmacology 1985 7 8 415 418 2-s2.0-0022249520 (Pubitemid 16253185)
17. Kułakowska A., Karwowska W., Wiśniewski K., Braszko J. J., Losartan influences behavioural effects of angiotensin II in rats. Pharmacological Research 1996 34 3-4 109 115 2-s2.0-0030240328 10.1006/phrs.1996.0073 (Pubitemid 27075999)
18. Raghavendra V., Chopra K., Kulkarni S. K., Involvement of cholinergic system in losartan-induced facilitation of spatial and short-term working memory. Neuropeptides 1998 32 5 417 421 2-s2.0-0031737223 10.1016/S0143-4179(98) 90065-8 (Pubitemid 28509005)
19. Inaba S., Iwai M., Furuno M., Tomono Y., Kanno H., Senba I., Okayama H., Mogi M., Higaki J., Horiuchi M., Continuous activation of renin-angiotensin system impairs cognitive function in renin/angiotensinogen transgenic mice. Hypertension 2009 53 2 356 362 2-s2.0-59849091253 10.1161/HYPERTENSIONAHA.108. 123612
20. Kazama K., Anrather J., Zhou P., Girouard H., Frys K., Milner T. A., Iadecola C., Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals. Circulation Research 2004 95 10 1019 1026 2-s2.0-8844227341 10.1161/01.RES.0000148637.85595.c5 (Pubitemid 39532332)
21. Wei Y., Whaley-Connell A. T., Chen K., Habibi J., Uptergrove G. M. E., Clark S. E., Stump C. S., Ferrario C. M., Sowers J. R., NADPH oxidase contributes to vascular inflammation, insulin resistance, and remodeling in the transgenic (mRen2) rat. Hypertension 2007 50 2 384 391 2-s2.0-34547637839 10.1161/HYPERTENSIONAHA.107.089284 (Pubitemid 47205789)
22. Didion S. P., Sigmund C. D., Faraci F. M., Impaired endothelial function in transgenic mice expressing both human renin and human angiotensinogen. Stroke 2000 31 3 760 765 2-s2.0-0034056523 (Pubitemid 30131667)
23. Faraci F. M., Lamping K. G., Modrick M. L., Ryan M. J., Sigmund C. D., Didion S. P., Cerebral vascular effects of angiotensin II: new insights from genetic models. Journal of Cerebral Blood Flow and Metabolism 2006 26 4 449 455 2-s2.0-33645849538 10.1038/sj.jcbfm.9600204
24. Lanz T. V., Ding Z., Ho P. P., Luo J., Agrawal A. N., Srinagesh H., Axtell R., Zhang H., Platten M., Wyss-Coray T., Steinman L., Angiotensin II sustains brain inflammation in mice via TGF- β Journal of Clinical Investigation 2010 120 8 2782 2794 2-s2.0-77955300852 10.1172/JCI41709
25. Liu G., Hosomi N., Hitomi H., Pelisch N., Fu H., Masugata H., Murao K., Ueno M., Matsumoto M., Nishiyama A., Angiotensin II induces human astrocyte senescence through reactive oxygen species production. Hypertension Research 2011 34 4 479 483 2-s2.0-79953690222 10.1038/hr.2010.269
26. Yamada K., Horita T., Takayama M., Effect of a centrally active angiotensin converting enzyme inhibitor, perindopril, on cognitive performance in chronic cerebral hypo-perfusion rats. Brain Research 2011 1421 1 10 120
27. Yamada K., Uchida S., Takahashi S., Takayama M., Nagata Y., Suzuki N., Shirakura S., Kanda T., Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimer's disease. Brain Research C 2010 1352 176 186 2-s2.0-77956178798 10.1016/j.brainres.2010.07.006
28. Van Nostrand W. E., Davis-Salinas J., Saporito-Irwin S. M., Amyloid β -protein induces the cerebrovascular cellular pathology of Alzheimer's disease and related disorders. Annals of the New York Academy of Sciences 1996 777 297 302 2-s2.0-0029873575 (Pubitemid 26149205)
29. Hardy J., Selkoe D. J., The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002 297 5580 353 356 2-s2.0-0037135111 10.1126/science.1072994 (Pubitemid 34790756)
30. Zou K., Michikawa M., Angiotensin-converting enzyme as a potential target for treatment of Alzheimer's disease: inhibition or activation? Reviews in the Neurosciences 2008 19 4-5 203 212 2-s2.0-57349100336
31. Wang B. R., Shi J. Q., Zhang Y. D., Zhu D. L., Shi J. P., Angiotensin II does not directly affect A β secretion or β -/ γ -secretase activity via activation of angiotensin II type 1 receptor. Neuroscience Letters 2011 500 2 103 107 2-s2.0-79960472517 10.1016/j.neulet.2011.06.014
32. Wang J., Ho L., Chen L., Zhao Z., Zhao W., Qian X., Humala N., Seror I., Bartholomew S., Rosendorff C., Pasinetti G. M., Valsartan lowers brain β -amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease. Journal of Clinical Investigation 2007 117 11 3393 3402 2-s2.0-36049002393 10.1172/JCI31547 (Pubitemid 350096995)
33. Tsukuda K., Mogi M., Iwanami J., Min L. J., Sakata A., Jing F., Iwai M., Horiuchi M., Cognitive deficit in amyloid- β -injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor- γ activation. Hypertension 2009 54 4 782 787 2-s2.0-70349682174 10.1161/HYPERTENSIONAHA.109.136879
34. Danielyan L., Klein R., Hanson L. R., Buadze M., Schwab M., Gleiter C. H., Frey W. H., Protective effects of intranasal losartan in the APP/PS1 transgenic mouse model of Alzheimer disease. Rejuvenation Research 2010 13 2-3 195 201 2-s2.0-77952342062 10.1089/rej.2009.0944
35. Dong Y. F., Kataoka K., Tokutomi Y., Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease. FASEB Journal 2011 25 9 2911 2920 10.1096/fj.11-182873
36. Hemming M. L., Selkoe D. J., Amyloid β -protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor. Journal of Biological Chemistry 2005 280 45 37644 37650 2-s2.0-27844534846 10.1074/jbc.M508460200 (Pubitemid 41642372)
37. Zou K., Maeda T., Watanabe A., Liu J., Liu S., Oba R., Satoh Y. I., Komano H., Michikawa M., A β 42-to-A β 40- and angiotensin-converting activities in different domains of angiotensin-converting enzyme. Journal of Biological Chemistry 2009 284 46 31914 31920 2-s2.0-70450257558 10.1074/jbc.M109.011437
38. Wharton W., Stein J. H., Korcarz C., The effects of ramipril in individuals at risk for Alzheimer's disease: results of a pilot clinical trial. Journal of Alzheimer's Disease 2012 32 1 147 156
39. Bhojak T. J., DeKosky S. T., Ganguli M., Kamboh M. I., Genetic polymorphism in the cathepsin G gene and the risk of Alzheimer's disease. Neuroscience Letters 2001 309 2 138 140 2-s2.0-0035943525 10.1016/S0304-3940(01) 02033-X (Pubitemid 32739152)
40. Kadir A., Almkvist O., Wall A., Långström B., Nordberg A., PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease. Psychopharmacology 2006 188 4 509 520 2-s2.0-33847250946 10.1007/s00213-006-0447-7 (Pubitemid 46758966)
41. Buckingham S. D., Jones A. K., Brown L. A., Sattelle D. B., Nicotinic acetylcholine receptor signalling: roles in alzheimer's disease and amyloid neuroprotection. Pharmacological Reviews 2009 61 1 39 61 2-s2.0-63849213473 10.1124/pr.108.000562
42. Wang H. Y., Lee D. H. S., D'Andrea M. R., Peterson P. A., Shank R. P., Reitz A. B., β -Amyloid1-42 binds to α 7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. Journal of Biological Chemistry 2000 275 8 5626 5632 2-s2.0-0034006944 10.1074/jbc.275.8.5626 (Pubitemid 30115201)
43. Parri H. R., Hernandez C. M., Dineley K. T., Research update: alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease. Biochemical Pharmacology 2011 82 8 931 942 2-s2.0-79960596590 10.1016/j.bcp.2011.06.039
44. Shaw S., Bencherif M., Marrero M. B., Angiotensin II blocks nicotine-mediated neuroprotection against β -amyloid (1-42) via activation of the tyrosine phosphatase SHP-1. Journal of Neuroscience 2003 23 35 11224 11228 2-s2.0-0346749449 (Pubitemid 37548958)
45. Marrero M. B., Bencherif M., Convergence of alpha 7 nicotinic acetylcholine receptor-activated pathways for anti-apoptosis and anti-inflammation: central role for JAK2 activation of STAT3 and NF- B. Brain Research C 2009 1256 1 7 2-s2.0-59649084358 10.1016/j.brainres.2008.11.053
46. Seguin L. R., Villarreal R. S., Ciuffo G. M., AT2 receptors recruit c-Src, SHP-1 and FAK upon activation by ang II in PND15 rat hindbrain. Neurochemistry International 2012 60 2 199 207 10.1016/j.neuint.2011.11.008
47. Li J. M., Mogi M., Tsukuda K., Tomochika H., Iwanami J., Min L. J., Nahmias C., Iwai M., Horiuchi M., Angiotensin II-induced neural differentiation via angiotensin II type 2 (AT2) receptor-MMS2 cascade involving interaction between AT 2 receptor-interacting protein and Src homology 2 domain-containing protein-tyrosine phosphatase 1. Molecular Endocrinology 2007 21 2 499 511 2-s2.0-33846563996 10.1210/me.2006-0005 (Pubitemid 46184898)
48. AbdAlla S., Lother H., El Missiry A., Langer A., Sergeev P., El Faramawy Y., Quitterer U., Angiotensin II AT2 receptor oligomers mediate G-protein dysfunction in an animal model of Alzheimer disease. Journal of Biological Chemistry 2009 284 10 6554 6565 2-s2.0-65249120870 10.1074/jbc.M807746200
49. Tienari P. J., De Strooper B., Ikonen E., Simons M., Weidemann A., Czech C., Hartmann T., Ida N., Multhaup G., Masters C. L., Van Leuven F., Beyreuther K., Dotti C. G., The β -amyloid domain is essential for axonal sorting of amyloid precursor protein. EMBO Journal 1996 15 19 5218 5229 2-s2.0-10144263284 (Pubitemid 26336205)
50. Iadecola C., The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathologica 2010 120 3 287 296 2-s2.0-77956231757 10.1007/s00401-010-0718-6
51. Girouard H., Park L., Anrather J., Zhou P., Iadecola C., Angiotensin II attenuates endothelium-dependent responses in the cerebral microcirculation through nox-2-derived radicals. Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 4 826 832 2-s2.0-33646710114 10.1161/01.ATV.0000205849.22807.6e (Pubitemid 43732158)
52. Capone C., Faraco G., Park L., Cao X., Davisson R. L., Iadecola C., The cerebrovascular dysfunction induced by slow pressor doses of angiotensin II precedes the development of hypertension. American Journal of Physiology-Heart and Circulatory Physiology 2011 300 1 H397 H407 2-s2.0-78651313012 10.1152/ajpheart.00679.2010
53. Girouard H., Lessard A., Capone C., Milner T. A., Iadecola C., The neurovascular dysfunction induced by angiotensin II in the mouse neocortex is sexually dimorphic. American Journal of Physiology-Heart and Circulatory Physiology 2008 294 1 H156 H163 2-s2.0-38349074450 10.1152/ajpheart.01137.2007
54. Laughlin G. A., McEvoy L. K., von Muhlen D., Sex differences in the association of Framingham cardiac risk score with cognitive decline in community-dwelling elders without clinical heart disease. Psychosomatic Medicine 2011 73 8 683 689 10.1097/PSY.0b013e31822f9089
55. Takeda S., Sato N., Takeuchi D., Kurinami H., Shinohara M., Niisato K., Kano M., Ogihara T., Rakugi H., Morishita R., Angiotensin receptor blocker prevented β -amyloid-induced cognitive impairment associated with recovery of neurovascular coupling. Hypertension 2009 54 6 1345 1352 2-s2.0-73349097900 10.1161/HYPERTENSIONAHA.109.138586
56. Zhang M., Mao Y., Ramirez S. H., Tuma R. F., Chabrashvili T., Angiotensin II induced cerebral microvascular inflammation and increased blood-brain barrier permeability via oxidative stress. Neuroscience 2010 171 3 852 858 2-s2.0-78349309457 10.1016/j.neuroscience.2010.09.029
57. Min L. J., Mogi M., Iwanami J., Sakata A., Jing F., Tsukuda K., Ohshima K., Horiuchi M., Angiotensin II and aldosterone-induced neuronal damage in neurons through an astrocyte-dependent mechanism. Hypertension Research 2011 34 6 773 778 2-s2.0-79958122331 10.1038/hr.2011.38
58. Horiuchi M., Mogi M., Iwai M., The angiotensin II type 2 receptor in the brain. Journal of the Renin-Angiotensin-Aldosterone System 2010 11 1 1 6 2-s2.0-77749298333 10.1177/1470320309347793
59. Iwai M., Liu H. W., Chen R., Ide A., Okamoto S., Hata R., Sakanaka M., Shiuchi T., Horiuchi M., Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation. Circulation 2004 110 7 843 848 2-s2.0-4143095706 10.1161/01.CIR.0000138848.58269.80 (Pubitemid 39096013)
60. Mogi M., Li J. M., Iwanami J., Min L. J., Tsukuda K., Iwai M., Horiuchi M., Angiotensin II type-2 receptor stimulation prevents neural damage by transcriptional activation of methyl methanesulfonate sensitive 2. Hypertension 2006 48 1 141 148 2-s2.0-33745993277 10.1161/01.HYP.0000229648.67883.f9 (Pubitemid 44297536)
61. Reinecke K., Lucius R., Reinecke A., Rickert U., Herdegen T., Unger T., Angiotensin II accelerates functional recovery in the rat sciatic nerve in vivo: role of the AT2 receptor and the transcription factor NF-kappaB. FASEB Journal 2003 17 14 2094 2096 2-s2.0-0642273041
62. Li J., Culman J., Hörtnagl H., Zhao Y., Gerova N., Timm M., Blume A., Zimmermann M., Seidel K., Dirnagl U., Unger T., Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury. FASEB Journal 2005 19 6 617 619 2-s2.0-20144389630 10.1096/fj.04-2960fje (Pubitemid 40471263)
63. Gendron L., Laflamme L., Rivard N., Asselin C., Payet M. D., Gallo-Payet N., Signals from the AT2 (angiotensin type 2) receptor of angiotensin II inhibit p21(ras) and activate MAPK (mitogen-activated protein kinase) to induce morphological neuronal differentiation in NG108-15 cells. Molecular Endocrinology 1999 13 9 1615 1626 2-s2.0-0033237655 (Pubitemid 30650600)
64. Cote F., Laflamme L., Payet M. D., Gallo-Payet N., Nitric oxide, a new second messenger involved in the action of angiotensin II on neuronal differentiation of NG108-15 cells. Endocrine Research 1998 24 3-4 403 407 2-s2.0-0032428097 (Pubitemid 29016414)
65. Côté F., Do T. H., Laflamme L., Gallo J. M., Gallo-Payet N., Activation of the AT2 receptor of angiotensin II induces neurite outgrowth and cell migration in microexplant cultures of the cerebellum. Journal of Biological Chemistry 1999 274 44 31686 31692 2-s2.0-0038190097 10.1074/jbc.274.44.31686 (Pubitemid 29508538)
66. Jing F., Mogi M., Sakata A., Direct stimulation of angiotensin II type 2 receptor enhances spatial memory. Journal of Cerebral Blood Flow and Metabolism 2011 32 2 248 255
67. Jöhren O., Dendorfer A., Dominiak P., Cardiovascular and renal function of angiotensin II type-2 receptors. Cardiovascular Research 2004 62 3 460 467 2-s2.0-2442568463 10.1016/j.cardiores.2004.01.011 (Pubitemid 38648960)